FDA — authorised 13 September 1988
- Application: ANDA063014
- Marketing authorisation holder: WATSON LABS INC
- Local brand name: PENICILLIN G SODIUM
- Indication: INJECTABLE — INTRAMUSCULAR, INTRAVENOUS
- Status: approved
🇺🇸 PENICILLIN G SODIUM in United States
FDA authorised PENICILLIN G SODIUM on 13 September 1988
Marketing authorisations
FDA — authorised 26 February 2001
- Application: ANDA065068
- Marketing authorisation holder: SANDOZ
- Local brand name: PENICILLIN G SODIUM
- Indication: INJECTABLE — INTRAMUSCULAR, INTRAVENOUS
- Status: approved
FDA
- Application: ANDA061935
- Marketing authorisation holder: BRISTOL MYERS SQUIBB
- Local brand name: PENICILLIN G SODIUM
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA
- Application: ANDA061046
- Marketing authorisation holder: PHARMACIA AND UPJOHN
- Local brand name: PENICILLIN G SODIUM
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA
- Application: ANDA061051
- Marketing authorisation holder: COPANOS
- Local brand name: PENICILLIN G SODIUM
- Indication: INJECTABLE — INJECTION
- Status: approved
PENICILLIN G SODIUM in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is PENICILLIN G SODIUM approved in United States?
Yes. FDA authorised it on 13 September 1988; FDA authorised it on 26 February 2001; FDA has authorised it.
Who is the marketing authorisation holder for PENICILLIN G SODIUM in United States?
WATSON LABS INC holds the US marketing authorisation.